Exforge Tablet, Film Coated
Product Images NDC 0078-0488

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Exforge (NDC 0078-0488). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Novartis Pharmaceuticals Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1: Probability Of Achieving Systolic Blood Pressure <140 Mmhg At Week 8 (Exforge 01)

FDA Label Image

Figure 2: Probability Of Achieving Diastolic Blood Pressure <90 Mmhg At Week 8 (Exforge 02)

FDA Label Image

Figure 3: Probability Of Achieving Systolic Blood Pressure <130 Mmhg At Week 8 (Exforge 03)

FDA Label Image

Figure 4: Probability Of Achieving Diastolic Blood Pressure <80 Mmhg At Week 8 (Exforge 04)

FDA Label Image

Amlodipine Besylate Structural Formula (Exforge 05)

FDA Label Image

Valsartan Structural Formula (Exforge 06)

FDA Label Image

Principal Display Panel Ndc 0078-0488-15 Exforge® (amlodipine And Valsartan) Tablets 5 mg*/160 mg *each Tablet Contains 6.9 mg Of Amlodipine Besylate 30 Tablets Rx Only Novartis (Exforge 07)

Principal Display Panel							Ndc 0078-0488-15							Exforge®							(amlodipine And Valsartan)							Tablets							5 mg*/160 mg							*each Tablet Contains 6.9 mg Of Amlodipine Besylate							30 Tablets							Rx Only							Novartis (Exforge 07)
This is a medication with the name "Exforge" which has the National Drug Code (NDC) of 0078:0488-15. It consists of 2 active ingredients, Amlodpine and Valsartan. The dosage strength of this medication is 6mg/160mg (amlodpine/valsartan) and comes in a pack of 30 tablets, which requires a prescription to be dispensed. The manufacturer of this drug is Novartis. The remaining text is not readable.*
FDA Label Image

Principal Display Panel Ndc 0078-0489-15 Exforge® (amlodipine And Valsartan) Tablets 10 mg*/160 mg *each Tablet Contains 13.9 mg Of Amlodipine Besylate 30 Tablets Rx Only Novartis (Exforge 08)

Principal Display Panel							Ndc 0078-0489-15							Exforge®							(amlodipine And Valsartan)							Tablets							10 mg*/160 mg							*each Tablet Contains 13.9 mg Of Amlodipine Besylate							30 Tablets							Rx Only							Novartis (Exforge 08)
This is a description of a medication called EXFORGE. It comes in the form of tablets with a dosage of 10mg/160mg and is available in a bottle of 30 tablets. The manufacturer of this medication is Novartis. The NDC (National Drug Code) number assigned to this medication is 0074048915. No further details are available from the provided text.*
FDA Label Image

Principal Display Panel Ndc 0078-0490-15 Exforge® (amlodipine And Valsartan) Tablets 5 mg*/320 mg *each Tablet Contains 6.9 mg Of Amlodipine Besylate 30 Tablets Rx Only Novartis (Exforge 09)

FDA Label Image

Principal Display Panel Ndc 0078-0491-15 Exforge® (amlodipine And Valsartan) Tablets 10 mg*/320 mg *each Tablet Contains 13.9 mg Of Amlodipine Besylate 30 Tablets Rx Only Novartis (Exforge 10)

Principal Display Panel							Ndc 0078-0491-15							Exforge®							(amlodipine And Valsartan)							Tablets							10 mg*/320 mg							*each Tablet Contains 13.9 mg Of Amlodipine Besylate							30 Tablets							Rx Only							Novartis (Exforge 10)
This appears to be a medical document for a prescription drug called "amlodipine and valsartan." The drug is contained in tablets that are 10mg/320mg each and there are 30 of them per container. The text also includes a product code and an NDC number but no further information is available.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.